Veranova Welcomes Dr. William Sanders as Global VP of Chemical Development Operations

See more

Veranova at CPHI Barcelona

See more

Veranova Strengthens Leadership Team: Victoria Brown Joins as SVP, Chief HR Officer

See more

Testing Innovative Analytical Waters

See more

Managing complexity with confidence: Q&A with Veranova CEO Mike Riley

See more

Veranova celebrates the 20th anniversary of Pharmorphix®

See more

Veranova celebrates first year as an independent CDMO

See more

Dr. Rohtash Kumar joins Veranova as Chief Technology Officer

See more

Solubility – meeting the challenge

See more

Veranova appoints Mike Riley as Chief Executive Officer

See more

Veranova proposes closure of Annan facility

See more

Celebrating Veranova’s women in science

See more

Veranova completes mid-scale API expansion at Edinburgh, UK facility

See more

In conversation with Niek Stapel, CEO of Veranova

See more

How can today’s CDMOs ensure they can meet tomorrow’s demands?

See more

Leading the way in Synthetic Chemistry

See more

Veranova at CPHI WW

See more

JM Health rebrands as Veranova following sale to Altaris Capital Partners

See more

Featured insights from our experts

Read more

Antibody-drug conjugate development: challenges and opportunities

By selectively delivering highly potent APIs to cancer cells, they offer a range of improved patient outcomes, including reduced side effects and higher drug tolerability.

Understanding the formation of cocrystals

Cocrystals play an increasingly vital role in drug development, with specialist techniques required to identify and develop them.

Continuous manufacturing (flow chemistry) - the future of pharmaceutical manufacturing

Continuous manufacturing offers several advantages over traditional batch manufacturing, including increased efficiency, reduced waste, and improved product quality.

Veranova is your next great decision

Discover new ways to advance your science with Veranova.

Contact us